Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.625
Bid: 1.60
Ask: 1.65
Change: 0.025 (1.56%)
Spread: 0.05 (3.125%)
Open: 1.60
High: 1.675
Low: 1.60
Prev. Close: 1.60
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: iEnergizer to depart; Unbound for sale

Fri, 19th May 2023 10:15

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

iEnergizer PLC, up 24% at 67 pence, 12-month range 29.5p-526p. The Noida, India-based IT service management firm says its shares will stop trading on AIM on Wednesday. In April, it said it was seeking cancellation, stating that staying on the stock exchange was "unlikely to provide the company with significantly wider access to capital", adding that the cost and legal implications of maintaining its admission to trading on AIM were "disproportionate" to the benefits.

----------

Genedrive PLC, up 16% at 23.70p, 12-month range 8.00p-48.86p. The point-of-care molecular diagnostics firm says the UK National Institute for Health & Care Excellence recommends in draft guidance that CYP2C19 genotyping should be used before clopidogrel administration in managing ischemic stroke patients. "Screening patients to assess their clopidogrel resistance status allows for alternative treatments and better clinical outcomes," the company explains. The NICE Committee included the firm's CYP2C19 ID test in its review. Genedrive notes the test is still in development. Awaits the UKCA marking on the test prior to NICE's final report, currently scheduled for October.

----------

AIM - LOSERS

----------

Velocys PLC, down 28% at 2.41p, 12-month range 2.20p-7.30p. The sustainable fuels technology company says the books are covered at around GBP6 million for its placing and retail offer. The books remain open. The fundraise was announced after the market close on Thursday, with an issue price of 2.5p for each. The price is a 26% discount to Thursday's closing price of 3.4p. Velocys had voiced concerns over its ability to continue as a going concern. It aims to raise at least GBP32 million by the placing, retail offer, open offer, as well as a conditional issuance of convertible loan notes to Carbon Direct Capital and potential further issuances of convertible loan notes and/or new ordinary shares to investors other than Carbon Direct Capital.

----------

Unbound Group PLC, down 23% at 2.51p, 12-month range 2.51p-35.94p. The stock reaches a 12-month low as the firm launches a strategic review, including a formal sales process. Unbound is the parent company for a retail group selling a range of brands focused on the 55+ demographic, including Hotter Shoes. The review is to explore its strategic options, and could include a full sale of the company. Unbound warns a temporary working capital shortfall could arise in September and October this year. It continues to work with its advisers and banking partners to raise additional funds or refinance its current facilities.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Apr 2018 12:56

Genedrive To Unveil Hepatitis C ID Kit In Singapore Exhibition

LONDON (Alliance News) - Molecular diagnostics firm Genedrive PLC said Tuesday it is to premiere its hepatitis C ID kit in the Asia Pacific at an in will

Read more
20 Mar 2018 13:59

Genedrive Confident For Future As Interim Loss Narrows On Lower Costs

LONDON (Alliance News) - Genedrive PLC said on Tuesday that its pretax loss narrowed in the first half of the financial year as financing costs reduced for six months to the a

Read more
13 Mar 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 March PrudentialFull Year ResultsDignityFull Year MacdonaldHalf 15

Read more
27 Jan 2017 09:42

Genedrive's revenues rise despite difficulties in India

(ShareCast News) - Genedrive, an AIM listed near patient molecular diagnostics diagnostics company, has progressed well in the second half despite difficulties faced with its Tuberculosis (TB) assay in India. Group revenues "significantly" rose to £2.8m for six months ended 31 December 2016, up f

Read more
16 Jan 2017 16:11

Genedrive supplies field test units to US DoD

(ShareCast News) - Manchester-based diagnostics company genedrive announced on Monday that it has supplied Genedrive units and assays to the United States Department of Defense for field trials, as part its $7.8m development programme for a handheld device to allow for the detection of biohazards su

Read more
17 Nov 2016 09:53

Genedrive Human Genotyping Test Gets EU Certification

Read more
11 Oct 2016 14:05

Genedrive's revenue rises while it re-focuses company

(ShareCast News) - AIM-listed molecular diagnostics company Genedrive's revenue grew as it re-focused to concentrate on its Genedrive platform, launched a new test in India and changed its name. For the year ended 30 June, the company, formerly Epistem, reported 12% growth in turnover to £5.1m, comp

Read more
11 Oct 2016 13:11

CORRECT: Genedrive Loss Widens As Product Sales Slow To Materialise

Read more
21 Sep 2016 08:43

Genedrive appoints Matthew Fowler CFO

(ShareCast News) - AIM-listed molecular diagnostic company Genedrive appointed Matthew Fowler as chief financial officer and a member of the board. He will start at a date to be confirmed shortly and will replace John Rylands who has been with company since 2002. Fowler joins Gendrive from Scapa Gr

Read more
2 Aug 2016 09:19

Genedrive Sees Strong Revenue Increase But Wider Annual Loss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.